ARCHIVES

Amgen, J&J Defend ESA Indications.

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | March 21, 2008

Download PDF Visit The Full Archive

Related Articles

MicroRNA Assay Detects Cancer Two Years Before LDCT in Study

January 31, 2014

Senate Outlines Budget Priorities In Bill Report

July 19, 1991

Scientific Community Rallies To Support DeVita; Immediate Suspension Of Straus’ Grant Considered

June 12, 1981

DCT Board Approves Drug Development Recompetition

November 30, 1990

NCI Natural Product Drug Development To Get New Emphasis; Suggestions Of Critic Accepted

March 19, 1976

Colorado Institutions Vying to Build First Carbon Ion Center in the U.S.

September 26, 2014